However, after an argument with his mother, a mathematics teacher, he applied to study medicine, and was accepted by University of New South Wales.
[4][6] He was also part of a group that in a clinical trial over six months showed, for the first time, that a monoclonal antibody could significantly reduce frequency and effects of migraine.
He subsequently trained, worked and studied with Don Reis at Cornell, USA; Jacques Seylaz at Universite VII, Paris, and post-graduate neurology training at the Institute of Neurology, London with C David Marsden, Andrew Lees, Anita Harding and W Ian McDonald.
He is also an Honorary Consultant Neurologist at the Great Ormond Street Hospital for Sick Children, UK and Professor of Neurology, University of California, Los Angeles.
[3] Peter Goadsby was awarded with the inaugural Lance Gold medal and Oration at the first Lance-Goadsby annual Mind, Migraine, Movement and More Symposium during 2018, organised by Tissa Wijeratne and team in Australia.
In March 2021, Goadsby and his collaborators Lars Edvinsson, Michael Moskowitz and Jes Olesen were awarded the Brain Prize 2021 for their work on the causes and treatment of migraine.